Liposomal Glutathione
SupplementThe community rates liposomal glutathione considerably more favorably than the medical evidence warrants [c1, c2, c3]. While clinical studies demonstrate increases in GSH biomarkers, no hard clinical endpoints have been shown in very small samples (n<70) [s1, s5]. The discrepancy is explained by the strong placebo effect on subjective energy parameters and by selective reporting of positive experiences in biohacking communities [c4, c5].
Unlock full information
Dosages, side effects, studies and more — free after registration.
Register for freeRating Scales
TL;DR
Liposomal glutathione demonstrably raises blood GSH levels better than conventional oral forms — multiple small RCTs confirm this — but whether that translates into any clinical benefit remains entirely unproven, as hard endpoints have never been studied. The community reports subjective gains in energy, skin quality, and reduced fatigue, particularly in Long COVID and detox circles, while healthy individuals often notice nothing. Two important caveats: oral supplementation likely reaches mitochondrial glutathione poorly, and supraphysiological GSH levels may be counterproductive under certain conditions. For most users, NAC or GlyNAC offer a cheaper route to endogenous GSH elevation with comparable or stronger evidence.
Description
Glutathione in liposomal encapsulation with improved oral bioavailability; used as an antioxidant, for detoxification support, and immunomodulation [s1, s2].
Glutathione (GSH) is an endogenous tripeptide composed of cysteine, glycine, and glutamic acid, and is considered the quantitatively most important intracellular antioxidant in the human body [s1]. It is present in all tissues, with particularly high concentrations in the liver [s4]. GSH levels decline with increasing age, in chronic disease, and under oxidative stress [s3]. Oral absorption of standard glutathione is severely limited by enzymatic degradation in the gastrointestinal tract (hydrolysis by gamma-glutamyltransferase) [s12]. Liposomal glutathione encapsulates the GSH molecule within microscopically small lipid bilayer vesicles (liposomes) that are structurally similar to cell membranes. This encapsulation protects GSH from degradation in the digestive tract and enables higher plasma availability compared to non-liposomal oral glutathione [s1, s2, s5]. In an RCT (Sinha et al., 2018) with 12 healthy men, daily intake of 500–1000 mg liposomal GSH over 4 weeks resulted in a measurable increase in whole blood and erythrocyte GSH levels, as well as improvements in select immune markers [s1]. A crossover study (Kern et al., 2024) compared liposomal GSH with standard GSH and found superior pharmacokinetics of the liposomal format in dose-corrected analysis [s5]. Note: The evidence base is limited. Existing clinical studies on liposomal glutathione have small sample sizes and short observation periods. Clinically relevant long-term data are largely absent [s1, s5]. Effects on skin brightening and neurological conditions are supported predominantly by in vitro or preliminary human data [s6, s8].
Legal Status (DE)
In Germany, Austria, and Switzerland, liposomal glutathione is freely available as a dietary supplement (food supplement). Dietary supplements are not subject to approval requirements but are classified as foodstuffs under EU Directive 2002/46/EC and corresponding national implementing legislation. The manufacturer bears responsibility for compliance with food law requirements. The BVL does not conduct prior review of marketability [s11, s12]. Injectable forms are not approved as medicinal products in the EU; the FDA has explicitly stated that L-glutathione is marketed only for dietary supplement purposes and is not suitable for sterile preparations [s10].
Mechanism of Action
Glutathione acts through several complementary mechanisms: 1. Direct free radical scavenging: GSH neutralizes reactive oxygen species (ROS) by transferring a hydrogen atom; this produces oxidized glutathione (GSSG), which is regenerated by glutathione reductase with consumption of NADPH [s1, s3]. 2. Detoxification: In the liver, GSH conjugates with electrophilic compounds (including heavy metals such as mercury, pesticides, and drug metabolites) via glutathione S-transferases. The resulting conjugates are excreted via bile or urine [s4]. 3. Immunomodulation: GSH regulates the proliferation and function of T cells and NK cells, as well as cytokine production. In the study by Sinha et al. (2018), NK cell activity and lymphocyte proliferation increased measurably after 4 weeks of liposomal GSH supplementation [s1]. 4. Melanin modulation (skin): GSH inhibits the enzyme tyrosinase, which is required for melanin synthesis, and shifts melanogenesis from eumelanin (dark brown) to pheomelanin (yellowish-red), which can produce a lightening of skin tone [s7]. 5. Neuroprotective effect: In an in vitro Parkinson's model (rat mesencephalic cultures, paraquat/maneb protocol), liposomal GSH was 100-fold more potent at replenishing intracellular GSH than non-liposomal GSH (EC50: 4.75 µM vs. 533 µM). No toxicity was observed up to 200-fold the EC50 concentration [s8]. Limitation: Whether orally administered liposomal GSH can effectively replenish mitochondrial GSH remains unclear. Available data suggest that cytosolic GSH elevation is moderate and the mitochondrial fraction is less effectively restored [c5].
Dosing
Allgemeiner Antioxidans-/Entgiftungsschutz
- Dose
- 250–500 mg GSH (liposomal)
- Frequency
- 1× täglich
- Route
- oral
- Duration
- 4–12 Wochen, dann Pause oder Evaluation
- Timing
- Fasted or 30 minutes before meals for optimal absorption
- With food
- optional
Erhöhung von GSH-Blutspiegeln (klinische Studie)
- Dose
- 500–1000 mg GSH (liposomal)
- Frequency
- 1× täglich
- Route
- oral
- Duration
- 4 Wochen
- Timing
- In the morning on an empty stomach
- With food
- vermeiden
No officially established upper limit by BfR or EFSA for glutathione in dietary supplements. In clinical studies, up to 1000 mg/day of liposomal GSH has been used without serious adverse effects [s1]. Doses above 1000 mg/day have not been sufficiently investigated clinically.
Liposomal formulations vary considerably in quality and actual GSH content. Administration should be taken on an empty stomach to minimize competition with dietary components. Combination with NAC (N-acetylcysteine) as a GSH precursor is possible, but pharmacological redundancy should be considered [c3, c4].
Side Effects
| Side Effect | Frequency | Severity |
|---|---|---|
| Milde gastrointestinale Beschwerden (Übelkeit, Blähungen, weicher Stuhl) In the RCT by Sinha et al. (2018), no serious adverse events were reported; all adverse events were minor and not clearly attributed to any treatment group [s1]. | gelegentlich | leicht |
| Hautausschlag (bei Überdosierung oder individueller Empfindlichkeit) Drugs.com reports the occurrence of skin reactions; no specific case numbers available [s9]. | selten | leicht |
| Kratzen im Hals, unangenehmer Schwefelgeschmack Community reports from DACH forums and Reddit occasionally describe an unpleasant taste with liposomal liquid preparations [c7, c1]. | gelegentlich | leicht |
| Leberfunktionsstörungen (bei intravenöser Anwendung) Hepatic dysfunction has been documented as a rare adverse effect of injectable glutathione preparations. Explicitly does NOT apply to oral liposomal formulations [s9]. | selten | schwer |
Contraindications
Inhaled glutathione can trigger bronchospasm. This contraindication applies to inhaled, not oral liposomal, forms [s9].
As a potent antioxidant, glutathione may attenuate the oxidative mechanism of certain chemotherapeutic agents (e.g., cisplatin, doxorubicin). Use only after consultation with the treating oncologist [s9].
Due to insufficient safety data for these populations, supplementation without medical recommendation is discouraged [s9].
Interactions
Synergistic
Vitamin C can regenerate oxidized glutathione (GSSG) to reduced GSH, thereby indirectly maintaining intracellular GSH levels. Mechanistically well established [s3].
NAC is a direct precursor of cysteine, the rate-limiting amino acid in endogenous GSH synthesis. Combination with liposomal GSH is theoretically synergistic, but pharmacological redundancy is possible. Community discussions advise against taking both simultaneously [c3, c4].
Alpha-lipoic acid can reduce GSSG to GSH, thereby mechanistically supporting the glutathione redox cycle [s3].
Caution
Theoretical attenuation of cytostatic efficacy via the antioxidant mechanism of GSH. No direct RCT evidence, but oncological consensus advises caution [s9].
GSH modulates immune function (NK cells, T cells). Theoretical interaction with immunosuppressants; clinical relevance unknown [s1, s9].
Studies
Tier A — High Evidence
Outcome: Pharmacokinetic parameters (AUC, Cmax) of GSH after 300 mg liposomal vs. 500 mg standard GSH (dose-corrected)
Effect Size: Liposomal formulation showed significantly higher dose-corrected bioavailability compared to standard GSH (p ≤ 0.05)
Outcome: GSH levels in whole blood, GSSG/GSH ratio (oxidative stress)
Effect Size: Significant increase in whole blood GSH after 6 months (1000 mg/d); reduction of GSSG/GSH ratio in both dose groups. No clinically relevant endpoints demonstrated.
Outcome: Changes in GSH levels in whole blood, erythrocytes, and plasma; NK cell activity, lymphocyte proliferation
Effect Size: ~28% increase in erythrocyte GSH in the high-dose group (1000 mg/d) after 1–2 weeks; significant improvement in NK cell activity and lymphocyte proliferation vs. placebo
Tier B — Moderate Evidence
Outcome: GSH levels following glutathione supplementation
Effect Size: Five included primary studies; GSH levels increased following supplementation; effects on oxidative stress biomarkers inconsistent. Quality assessment: predominantly low to moderate.
Outcome: Skin lightening/skin whitening by systemic glutathione
Effect Size: Multiple in vitro studies demonstrate tyrosinase inhibition; clinical human studies very small and short-term; no long-term data.
Tier C — Low Evidence
Outcome: Replenishment of intracellular GSH and neuroprotective effect in a Parkinson's model (paraquat/maneb)
Effect Size: Liposomal GSH 100-fold more potent than non-liposomal GSH (EC50: 4.75 µM vs. 533 µM). No toxicity up to 200× EC50. Not transferable to humans.
Community Evidence
Top reported benefits
- Subjectively perceived increase in energy and mood
- Improved skin appearance (brightness, evenness)
- Sense of improved detoxification (especially after alcohol consumption or toxic exposure)
- Reduced fatigue in long COVID / chronic exhaustion
Top reported issues
- High costs with unclear evidence of benefit
- Unpleasant sulfurous taste in liquid formulations
- No noticeable effect in healthy individuals
- Uncertainty regarding quality and actual GSH content of various products
Critical Reddit posts indicate that liposomal GSH may inadequately restore mitochondrial glutathione, and that supraphysiological GSH levels could potentially be detrimental under certain conditions (antioxidant paradox) [c4, c5]. Some community members prefer NAC or GlyNAC (glycine + NAC) as more cost-effective alternatives for endogenous GSH elevation [c3, c5].
Scientific Sources
- Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function
Sinha R, Sinha I, Calcagnotto A, et al. (2018). European Journal of Clinical NutritionAPMID:28853742DOI - FDA highlights concerns with using dietary ingredient glutathione to compound sterile injectables
U.S. Food and Drug Administration (2022). FDA.govALink - Nahrungsergänzungsmittel - BVL Bundesamt für Verbraucherschutz und Lebensmittelsicherheit
Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL) (2023). BVL.bund.deALink - Glutathion - Anwendung, Wirkung, Nebenwirkungen
Gelbe Liste Pharmaindex Redaktion (2023). Gelbe-Liste.deBLink - Glutathione Levels after Glutathione Supplementation: A Systematic Review and Meta-analysis
Unidentified authors (journal article) (2024). Journal of Current Science and TechnologyALink - Randomized controlled trial of oral glutathione supplementation on body stores of glutathione
Richie JP, Nichenametla S, Neidig W, et al. (2015). European Journal of NutritionAPMID:24791752DOI - Liposomal Glutathion: Der ultimative Guide zum Hauptantioxidant des Körpers
Intelligent Labs Editorial Team (2023). Intelligent Labs Blog (DE)CLink - A Targeted Metabolomic Assessment of Oral Glutathione Bioavailability and Safety in Humans: A Randomized Crossover Clinical Trial
Kern JK, Bjørklund G, Mehta JA, et al. (2024). PMC / Nutrients (preprint/publication)ALink - Systemic Glutathione as a Skin-Whitening Agent in Adults
Sonthalia S, Daulatabad D, Sarkar R (2016). Journal of Pigmentary Disorders / PMCBPMID:27088927DOI - Glutathione as a skin whitening agent: Facts, myths, evidence and controversies
Sonthalia S, Jha AK, Lallas A, et al. (2016). Indian Dermatology Online JournalBPMID:27088927 - Liposomal-glutathione provides maintenance of intracellular glutathione and neuroprotection in mesencephalic neuronal cells
Zeevalk GD, Bernard LP, Guilford FT (2010). Neurochemical ResearchCPMID:20535554DOI - Glutathione Uses, Benefits and Dosage
Drugs.com Editorial Staff (2024). Drugs.comCLink
Community Sources
Storage
Unopened
Store cool (8–15 °C), protected from light. Liquid liposomal preparations are often stored refrigerated (4–8 °C) per manufacturer's instructions.
Opened
After opening, store in the refrigerator and use within the manufacturer's specified period (typically 30–60 days). Capsules/powder: keep tightly sealed, dry, and protected from heat.
Notes
Liposomal formulations are more sensitive to heat and light than standard powders. Freezing can damage the liposome structure.